AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

RABEPRAZOLE+DOMPERIDONE

9 registrations across 3 African markets— 5 active

Markets with RABEPRAZOLE+DOMPERIDONE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Hyperex-SR Capsules (check pack size)
Capsule
🇳🇬NigeriaLeotetra Healthcare LtdactiveNov 2028
Rabikol
Capsule
🇳🇬NigeriaAkol Healthcare LimitedactiveJul 2028
Ethirab-D Capsules
Capsule
🇳🇬NigeriaPharma Ethics LimitedactiveOct 2026
Rabell-Dsr+++
Tablet
🇳🇬NigeriaBellBag Pharmaceuticals LtdactiveJun 2025
ROBEZOLE-D 20MG/30MG GELULE BOITE DE 15🇨🇮Côte d'IvoireLABORATOIRES MORACEAE PHARMACEUTICALSPVTexpiredOct 2024
RABETOK-D 20MG/30MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoireINDOLANDS PHARMA PVT LTDexpiredDec 2023
RAVZOLE-D 20MG/20MG GELULE BOITE DE 30🇨🇮Côte d'IvoireZYDUS LIFESCIENCES LIMITEDexpiredJan 2021
ORAB D COMPRIME BOITE DE 30🇨🇮Côte d'IvoireCONSULTING PHARMA FORMULATIONSexpiredJan 2021
RABETOK-D
gélule / 20 mg / 30 mg
🇸🇳SenegalINDOLAANDS PHARMA PVT. LTD. VARDHMAN CROWN MALL, PLOT NO.2, LCS SECTO-19, DWARKA NEW DELHI-110041, INDEactive

RABEPRAZOLE+DOMPERIDONE in Africa — Regulatory Overview

RABEPRAZOLE+DOMPERIDONE is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Nigeria, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 5 (56%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.